XML 46 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following fair value hierarchy table presents information about the Company’s financial assets and liabilities measured at fair value (in thousands):
 
 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
March 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
2,179,211

 
$

 
$

 
$
2,179,211

Corporate debt
 
91,314

 

 

 
91,314

U.S. government and Non-U.S. government obligations
 
37,618

 

 

 
37,618

Listed options
 
12,299

 

 

 
12,299

Total Financial instruments owned, at fair value
 
2,320,442

 

 

 
2,320,442

Investments(1)
 
2,379

 
2,234

 

 
4,613

Other (2)
 

 
54,142

 
2,838

 
56,980

Total assets held at fair value
 
$
2,322,821

 
$
56,376

 
$
2,838

 
$
2,382,035

Liabilities
 

 
 
 

 

Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
1,694,374

 
$

 
$

 
$
1,694,374

Corporate debt
 
85,926

 

 

 
85,926

U.S. government and Non-U.S. government obligations
 
91,242

 

 

 
91,242

Listed options
 
35,835

 

 

 
35,835

Foreign currency forward contracts
 

 
598

 

 
598

Total liabilities held at fair value
 
$
1,907,377

 
$
598

 
$

 
$
1,907,975


(1) 
Investments comprise $2.4 million of Level 1 investments in CME Group and $2.2 million of Level 2 investments primarily related to deferred compensation investments, all of which are included within Investments on the Consolidated Statements of Financial Condition. See Footnote 8 "Investments" for additional information.
(2) 
Other primarily consists of a $54.1 million receivable from Bats related to the sale of KCG Hotspot and a $2.8 million receivable from the sale of an investment, both of which are included within Other Assets on the Consolidated Statements of Financial Condition.

 
 
Assets and Liabilities Measured at
Fair Value on a Recurring Basis
December 31, 2016
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Financial instruments owned, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
2,343,033

 
$

 
$

 
$
2,343,033

Corporate debt
 
127,237

 

 

 
127,237

U.S. government and Non-U.S. government obligations
 
50,461

 

 

 
50,461

Listed options
 
19,100

 

 

 
19,100

Foreign currency forward contracts
 

 
30

 

 
30

Total Financial instruments owned, at fair value
 
2,539,831

 
30

 

 
2,539,861

Investments (1)
 
9,198

 
2,286

 

 
11,484

Other (2)
 

 
60,538

 
2,846

 
63,384

Total assets held at fair value
 
$
2,549,029

 
$
62,854

 
$
2,846

 
$
2,614,729

Liabilities
 
 
 
 
 
 
 
 
Financial instruments sold, not yet purchased, at fair value:
 
 
 
 
 
 
 
 
Equities
 
$
1,821,957

 
$

 
$

 
$
1,821,957

Listed options
 
12,961

 

 

 
12,961

U.S. government obligations
 
87,661

 

 

 
87,661

Corporate debt
 
123,561

 

 

 
123,561

Total liabilities held at fair value
 
$
2,046,140

 
$

 
$

 
$
2,046,140


(1) 
Investments comprise $9.2 million of Level 1 investments in CME Group and Bats and also includes $2.3 million of Level 2 investments primarily related to deferred compensation investments, all of which are included within Investments on the Consolidated Statements of Financial Condition. See Footnote 8 "Investments" for additional information.
(2) 
Other primarily consists of a $60.5 million receivable from Bats related to the sale of KCG Hotspot and a $2.8 million receivable from the sale of an investment, both of which are included in Other assets on the Consolidated Statements of Financial Condition.
Changes in Fair Value of Financial Assets Categorized within Level 3
The following is a summary of changes in fair value of the Company's financial assets that have been categorized within Level 3 of the fair value hierarchy at March 31, 2017 and December 31, 2016 (in thousands):
 
Level 3 Financial Assets as of March 31, 2017
 
Balance at January
1, 2017
 
Realized gains(losses) during period
 
Unrealized gains (losses) during the period
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Transfers in or (out) of Level 3
 
Balance at March 31, 2017
Receivable from sold investment
$
2,846

 
$

 
$
(8
)
 
$

 
$

 
$

 
$

 
$

 
$
2,838

 
Level 3 Financial Assets as of December 31, 2016
 
Balance at January
1, 2016
 
Realized gains(losses) during period
 
Unrealized gains (losses) during the period
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Transfers in or (out) of Level 3
 
Balance at December 31, 2016
Receivable from sold investment
$
5,789

 
$

 
$
980

 
$

 
$

 
$
(3,923
)
 
$

 
$

 
$
2,846